Examining the Impact of Sirolimus on Ketamine's Antidepressant Effects

PHASE2CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

January 31, 2020

Study Completion Date

January 31, 2020

Conditions
Depression
Interventions
DRUG

Ketamine

. Subjects will receive an infusion of ketamine (0.5 mg/kg infusion over approximately 40 minutes). All subjects will receive two ketamine infusions-once with a placebo and once with a single dose of sirolimus (6 mg, oral administration).

DRUG

sirolimus

Subjects will receive a single 6 mg oral dose via oral solution of sirolimus or a dose of placebo approximately two hours prior to the infusions. As above, the order of placebo and sirolimus is randomized. The sirolimus dose as well as the placebo solution will be given in 6 ounces of orange juice.

DRUG

Placebo

Placebo oral dose

Trial Locations (2)

06511

Yale New Haven Hospital, New Haven

06516

West Haven Veterans Affairs, West Haven

All Listed Sponsors
lead

Yale University

OTHER

NCT02487485 - Examining the Impact of Sirolimus on Ketamine's Antidepressant Effects | Biotech Hunter | Biotech Hunter